Med Hypotheses. 2010 May;74(5):761-3. doi: 10.1016/j.mehy.2010.02.015. Epub 2010 Mar 12.
Just as a placebo can mimic an immediately effective drug so chronic drug dependence may mimic an effective long-term or preventive treatment. The discovery of the placebo had a profound result upon medical practice, since it became recognized that it was much harder to determine the therapeutic value of an intervention than was previously assumed. Placebo is now the null hypothesis for therapeutic improvement. As David Healy describes in the accompanying editorial on treatment induced stress syndromes [1], an analogous recognition of the effect of drug dependence is now overdue. Drug dependence and withdrawal effects should in future become the null hypothesis when there is clinical deterioration following cessation of treatment. The ideal methodology for detecting drug dependence and withdrawal is a double-blind placebo controlled and randomized trial using disease-free normal control subjects. Normal controls are necessary to ensure that the possibility of underlying chronic disease is eliminated: so long as subjects begin the trial as 'normal controls' it is reasonable to infer that any clinical or psychological problems (above placebo levels) which they experience following drug withdrawal can reasonably be attributed to the effects of the drug. This is important because the consequences of failing to detect the risk of covert drug dependence may be considerably worse than failing to detect a placebo effect. Drug dependent patients not only fail to receive benefit and suffer continued of inconvenience, expense and side effects; but the drug has actually created and sustained a covert chronic pathology. However, the current situation for drug evaluation is so irrational that it would allow chronic alcohol treatment to be regarded as a cure for alcoholism on the basis that delirium tremens follows alcohol withdrawal and alcohol can be used to treat delirium tremens! Therefore, just as placebo controlled trials of drugs are necessary to detect ineffective drugs, so drug withdrawal trials on normal control subjects should be regarded as necessary to detect dependence-producing drugs.
就像安慰剂可以模拟立即有效的药物一样,慢性药物依赖也可能模拟有效的长期或预防治疗。安慰剂的发现对医学实践产生了深远的影响,因为人们认识到,确定干预措施的治疗价值比以前想象的要困难得多。现在,安慰剂是治疗效果的零假设。正如 David Healy 在随附的关于治疗引起的应激综合征的社论[1]中所描述的,现在也应该认识到药物依赖的影响。在停止治疗后出现临床恶化时,药物依赖和戒断效应应该成为未来的零假设。检测药物依赖和戒断的理想方法是使用无病正常对照受试者进行双盲安慰剂对照和随机试验。正常对照是必要的,以确保消除潜在慢性疾病的可能性:只要受试者作为“正常对照”开始试验,就可以合理推断,他们在停药后经历的任何临床或心理问题(高于安慰剂水平)都可以合理归因于药物的作用。这很重要,因为未能检测到隐性药物依赖的风险的后果可能比未能检测到安慰剂效应的后果严重得多。药物依赖患者不仅没有受益,而且还继续遭受不便、费用和副作用的困扰;但药物实际上已经产生并维持了一种隐性的慢性病理。然而,目前的药物评估情况如此不合理,以至于可以认为慢性酒精治疗可以治愈酒精中毒,因为震颤谵妄是在酒精戒断后发生的,而且酒精可以用于治疗震颤谵妄!因此,就像需要安慰剂对照试验来检测无效药物一样,也应该将对正常对照受试者进行药物戒断试验视为检测产生依赖性药物的必要手段。